Immunobiology of visceral leishmaniasis

Clinical Immunology and Immunopathology

Volumn 78, Issue 2, 1996, Pages 105-111

  Tanner, Charles E ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

DOWN REGULATION; GENE CONTROL; HOST RESISTANCE; HUMAN; IMMUNOPATHOLOGY; LEISHMANIA DONOVANI; MACROPHAGE; MOUSE; NONHUMAN; PARASITE TRANSMISSION; PRIORITY JOURNAL; REVIEW; VACCINATION; VISCERAL LEISHMANIASIS;

EID: 0029938982     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1996.0019     Document Type: Review

References (65)

1. Lainson, R., and Shaw, J. J., Evolution, classification and geographical distribution. In "The Leishmaniases in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), pp. 1-120, Academic Press, London, 1987.
2. Gemetche, T., The morphology and fine structure of the midgut and peritrophic membrane of the adult female, Phlebotomus longipes Parrot and Martin (Diptera: Psychodidae). Ann. Trop. Med. Parasitol. 68, 111-124, 1974.
3. Shortt, H. E., Smith, R. O. A., Swaminath, C. S., and Krishnan, K. V., Transmission of Indian kala-azar by the bite of Phlebotomus argentipes. Ind. J. Med. Res. 18, 1373-1375, 1931.
4. Sacks, D. L., and Perkins, P. V., Development of infective stage of Leishmania promastigotes within phlebotomine sand flies. Am. J. Trop. Med. Hyg. 34, 456-459, 1985.
5. Sacks, D. L., Hieny, S., and Sher, A., Identification of cell surface carbohydrate and antigenic changes between noninfective and infective developmental stages of Leishmania major promastigotes. J. Immunol. 135, 564-569, 1985.
6. Chang, K. P., Leishmania donovani: Promastigote-macrophage surface interactions in vitro. Exp. Parasitol. 48, 175-189, 1979.
7. Bray, R. S., Leishmania: Chemotactic responses of promastigotes and macrophages in vitro. J. Protozool. 30, 322-329, 1983.
8. Russell, D. G., and Talamas-Rohana, P., Leishmania and the macrophage: A marriage of inconvenience. Immunol. Today 10, 328-336, 1989.
9. Eslami, Z., and Tanner, C. E., Time course and intensity of infection in vitro in the resident peritoneal macrophages of resistant and susceptible mice exposed to different doses of Leishmania donovani promastigotes. Int. J. Parasitol. 24, 743-747, 1994.
10. Bray, R. S., and Alexander, J., Leishmania and the macrophage. In "The Leishmaniae in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), pp. 211-233, Academic Press, London, 1987.
11. Chang, K. P., and Dwyer, D. M., Leishmania donovani: Hamster macrophage interactions in vitro: Cell entry, intracellular survival and multiplication of amastigotes. J. Exp. Med. 147, 515-530, 1978.
12. Lewis, D. H., and Peters, W., The resistance of intracellular Leishmania parasites to digestion by lysosomal enzymes. Annu. Rev. Trop. Med. Parasitol. 71, 295-312, 1977.
13. Descoteaux, A., and Matlashewski, G., C-fos and TNF gene expression in Leishmania donovani-infected macrophages. Mol. Cell. Biol. 9, 5223-5227, 1989.
14. Moore, K. J., and Matlashewski, G., Intracellular infection by Leishmania donovani inhibits macrophage apoptosis. J. Immunol. 152, 2930-2937, 1994.
15. van Furth, R., "Mononuclear Phagocytes," Nijhoff, The Hague, 1980.
16. Griffiths, W. A. D., Old world cutaneous leishmaniasis. In "The Leishmaniases in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), pp. 618-636, Academic Press, London, 1987.
17. Manson-Bahr, P. E. C., East-African kala-azar with special reference to the pathology, prophylaxis and treatment. Trans. R. Soc. Trop. Med. Hyg. 53, 123-137, 1959.
18. Rees, P. H., and Karger, P. A., Visceral leishmaniasis and postkala-azar dermal leishmaniasis. In "The Leishmaniases in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), pp. 583-615, Academic Press, London, 1987.
19. Bradley, D. J., and Kirkley, J., Regulation of Leishmania populations within the host. I. The variable course of Leishmania donovani infection in mice. Clin. Exp. Immunol. 30, 119-129, 1977.
20. Vidai, S. M., Malo, D., Vogan, K., Skamene, E., Olivier, M., Jothy, S., and Gros, P., Natural resistance to infection with intracellular parasites: Isolation of a candidate for Beg. Cell 73, 469-485, 1993.
21. Vidai, S. M., Tremblay, M. L., Gavoni, G., Gauthier, S., Sebastiani, G., Malo, D., Skamene, E., Olivier, M., Jothy, S., and Gros, P., The Ity/Lsh/Bcg locus: Natural resistance to infection with intracellular parasites is abrogated by disruption of the Nramp1 gene. J. Exp. Med. 182, 655-666, 1995.
22. Howard, J. G., Hale, C., and Chan-Liew, W. L., Immunological regulation of experimental cutaneous leishmaniasis. I. Immunogenetic aspects of susceptibility to Leishmania tropica in mice. Parasite Immunol. 2, 303-314, 1980.
23. Mauel, J., and Behin, R., Leishmaniasis: Immunity, immunopathology and immunodiagnosis. In "Immunology of Parasite Infections" (S. Cohen and K. S. Warren, Eds.), pp. 299-325, Blackwell, London, 1982.
24. Blackwell, J. M., Leishmania donovani infection in heterozygous and recombinant H-2 haplotype mice. Immunogenetics 18, 101-109, 1983.
25. Crocker, P. R., Blackwell, J. M., and Bradley, D. J., Expression of the natural resistance gene Lsh in resident liver macrophages. Infect. Immun. 43, 1033-1040, 1984.
26. Olivier, M., and Tanner, C. E., Susceptibilities of macrophage populations to infection in vitro by Leishmania donovani. Infect. Immun. 55, 467-469, 1987.
27. Olivier, M., Bertrand, S., and Tanner, C. E., Killing of Leishmania donovani by activated liver macrophages from resistant and susceptible strains of mice. Int. J. Parasitol. 19, 377-383, 1989.
28. H2 responses in a murine model of cutaneous leishmaniasis. J. Immunol. 147, 3149-3155, 1991.
29. Locksley, R. M., Reiner, S. L., Hatam, F., Littman, D. R., and Kileen, N., Helper T cells without CD4: Control of leishmaniasis in CD-4 deficient mice. Science 261, 1448-1451, 1993.
30. H2-derived cytokines does not determine the genetically-controlled or vaccine-induced rate of cure in murine visceral leishmaniasis. J. Immunol. 146, 2763-2770, 1991.
31. Mauel, J., and Behin, R., Immunity: Clinical and experimental. In "The Leishmaniases in Biology and Medicine" (W. Peters and R. Killick-Kendrick, Eds.), pp. 731-791, Academic Press, London, 1987.
32. Adler, S., Leishmania. In "Advances in Parasitology" (B. Dawes, Ed.), Vol. 2, pp. 35-96, Academic Press, New York, 1964.
33. Neva, F., and Sacks, D. L., Leishmaniasis. In "Tropical and Geographical Medicine" (K. S. Warren and A. A. F. Mahmoud, Eds.), pp. 296-308, McGraw-Hill, New York, 1980.
34. Galvao-Castro, B., SaFerreira, J. A., Marzochi, K. F., Marzochi, M. C., Coutinho, S. G., and Lambert, P.-H., Polyclonal B cell activation, circulating immune complexes and autoimmunity in American visceral leishmaniasis. Clin. Exp. Immunol. 56, 58-66, 1984.
35. Allain, D. S., and Kagan, I. G., A direct agglutination test for leishmaniasis. Am. J. Trop. Med. Hyg. 24, 232-236, 1975.
36. Kohanteb, J., Ardehali, S. M., and Rezai, H. R., Detection of Leishmania donovani soluble antigen and antibody in the urine in visceral leishmaniasis patients. Trans. R. Soc. Trop. Med. Hyg. 81, 578-580, 1987.
37. Adler, S., and Gunders, A. E., Immunity to Leishmania mexicana following spontaneous recovery from oriental sore. Trans. R. Soc. Trop. Med. Hyg. 58, 274-277, 1964.
38. Wozencraft, A. O., Sayers, G., and Blackwell, J. M., Macrophage type 3 complement receptors mediate serum-independent binding of Leishmania donovani. J. Expt. Med. 164, 1332-1337, 1989.
39. Mosser, D. M., Wedgwood, J. F., and Edelson, P. J., Leishmania amastigotes: Resistance to complement-mediated lysis is not due to the failure to fix C3. J. Immunol. 134, 4128-4131, 1985.
40. Manson-Bahr, P. E. C., Immunity in kala-azar. Trans. R. Soc. Trop. Med. Hyg. 55, 550-555, 1961.
41. Klein, J., "Immunology," Blackwell, Cambridge, 1990.
42. Reiner, N. R., Ng, W., and McMaster, W. R., Parasite accessory cell interactions in murine leishmaniasis.II. Leishmania donovani suppresses macrophage expression of class I and class II major histocompatibility gene products. J. Immunol. 138, 1926-1932, 1987.
43. Reiner, N. R., Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus dependent suppression of the macrophage Interleukin 1 response. J. Immunol. 138, 1919-1925, 1987.
44. Rodriguez, V. Jr., Santana da Silva, J., and Campos-Neto, A., Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate T cell proliferation to parasite antigens. Parasite Immunol. 14, 49-58, 1992.
45. Reiner, N. R., and Finke, J. H., Interleukin-2 deficiency in murine leishmaniasis donovani and its relationship to depressed spleen cell response to phytohemagglutinin. J. Immunol. 131, 1487-1491, 1983.
46. Carvalho, E. M., Badaro, B., Reed, S. G., Jones, T. C., and Johnson, W. D., Absence of gamma interferon and interleukin II production during active visceral leishmaniasis. J. Clin. Invest. 76, 2066-2069, 1985.
47. Olivier, M., and Tanner, C. E., The effect of Cyclosporin A in murine visceral leishmaniasis. Trop. Med. Parasitol. 40, 32-38, 1989.
48. Carvalho, E. M., Teixeira, R. S., and Johnson, W. D., Cell mediated immunity in American visceral leishmaniasis: Reversible immunosuppression during acute infection. Infect. Immun. 33, 498-502, 1981.
49. Wyler, D. J., Circulating factor from kala azar patients suppresses in vitro antileishmanial T cell proliferation. Trans. R. Soc. Trop. Med. Hyg. 76, 304-306, 1982.
50. Ho, M., Koech, D. K., Iha, D. W., and Bryceson, A. D. M., Immunosuppression in Kenyan visceral leishmaniasis. Clin. Exp. Immunol. 51, 207-214, 1988.
51. Barrai, A., Carvalho, E. M., Badaro, R., and Barral-Neto, M., Suppression of lymphocyte proliferation responses by sera from patients with American visceral leishmaniasis. Am. J. Trop. Med. Hyg. 35, 735-742, 1986.
52. Engelhorn, S., Bruckner, A., and Remold, H. G., A soluble factor produced by inoculation of human monocytes with Leishmania donovani promastigotes suppresses IFN-γ-dependent monocyte activation. J. Immunol. 145, 2662-2668, 1990.
53. Blackwell, J. M., and Ulczak, O. M., Immunoregulation of genetically acquired responses to Leishmania donovani infection in mice: Demonstration and characterization of suppressor cells in non-cure mice. Infect. Immun. 44, 97-102, 1984.
54. Nickol, A. D., and Bonventre, P. F., Visceral leishmaniasis in congenic mice of resistant and susceptible phenotype: Immunosuppression by adherent spleen cells. Infect. Immun. 50, 160-168, 1985.
55. Pearson, R. D., Marcus, J. L., Roberts, D., and Donowitz, G. R., Differential survival of Leishmania donovani amastigotes in human monocytes. J. Immunol. 131, 1994-1999, 1983.
56. Lepay, D. A., Nathan, C. F., Steinman, R. M., Murray, H. W., and Cohn, Z. A., Murine Kupffer cells: Mononuclear phagocytes defficient in the generation of reactive oxygen intermediates. J. Exp. Med. 151, 1079-1096, 1985.
57. Roach, T. I. A., Kiderlen, A. F., and Blackwell, J. M., Role of inorganic nitrogen oxides and tumor necrosis factor alpha in killing Leishmania donovani amastigotes in gamma-interferon-lipopolysaccharide-activated macrophages. Infect. Immun. 59, 3935-3944, 1991.
58. Olivier, M., Baimbridge, K. G., and Reiner, N. R., Inhibition of N-formyl-methyonyl-leucyl-phenylalanine-induced stimulus-response coupling in monocytes infected with leishmania: Evidence for a defect in agonist-induced calcium release. J. Immunol. 148, 1188-1196, 1992.
59. Olivier, M., Brownsey, R. W., and Reiner, N. R., Defective stimulus-response coupling in human monocytes infected with Leishmania donovani is associated with altered activation of protein kinase C. Proc. Natl. Acad. Sci. USA 89, 7841-7845, 1992.
60. +2 by protozoan parasites. Parasitol. Today, in press, 1996.
61. +2 of the host cell on the capacity of Trypanosoma cruzi to invade and multiply intracellularly. J. Parasitol. 81, 597-602, 1996.
62. Murray, H. W., Spitalny, G. L., and Nathan, C. F., Activation of mouse peritoneal macrophages in vitro and in vivo by interferon-γ. J. Immunol. 134, 1619-1622.
63. Eslami, Z., Olivier, M., and Tanner, C. E., Immunotherapy with IL-2-stimulated splenocytes reduces in vitro the level of Leishmania donovani infection in peritoneal macrophages. Int. J. Parasitol. 25, 975-981, 1995.
64. Olivier, M., Eslami, Z., and Tanner, C. E., IL-2-stimulated splenocytes reduce infections by Leishmania donovani in vivo. J. Parasitol. 82, in press, 1996.
65. Eslami, Z., Gaucher, D., and Tanner, C. E., Synergism of IL-2-stimulated spleen cells and Pentostam enhances the killing of Leishmania donovani in vitro. Submitted for publication.